MedTrace Logo

Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients

NCT02359123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2018-04-10

No results posted yet for this study

Summary

The main purpose in the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS) is to prolong life and to improve quality of life (QoL) as far as possible. QoL in patients with CACS is directly related to loss of appetite and loss of weight. Cannabis pills are given in Israel to advanced cancer patients with various symptoms in order to improve their QoL. There is data on safety/toxicity of cannabis, and these pills are given under the regulations of the Israel Ministry of Health.

The purpose of this study is to examine the influence of Cannabics capsules on improving loss of appetite and loss of weight.

Conditions

  • Cancer Cachexia
  • Atypical Anorexia Nervosa

Interventions

OTHER

Cannabics capsules

Cannabis extract in an oil formulation

Sponsors & Collaborators

  • Cannabics Pharmaceuticals Inc.

    lead INDUSTRY

Principal Investigators

  • Gil Bar-Sela, Md · Rambam MC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-04-01
Completion
2018-04-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02359123 on ClinicalTrials.gov